No effect of protease inhibitor on clinical and virological evolution of Castleman's disease in an HIV-1-infected patient.
Dupin
N
N
Krivine
A
A
Calvez
V
V
Gorin
I
I
Franck
N
N
Escande
J P
JP
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D005871:Castleman Disease / Q000175:diagnosis* / Q000188:drug therapy*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1; D019288:Herpesvirus 8, Human / Q000187:drug effects / Q000254:growth & development; D018451:Homosexuality, Male; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use*; D008297:Male; D012367:RNA, Viral / Q000032:analysis
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D012367:RNA, Viral; D019469:Indinavir